Non-Small Cell Lung Cancer Market (COVID-19) to Witness Astonishing Growth by Forecast 2019-2026 - PowerPoint PPT Presentation

About This Presentation
Title:

Non-Small Cell Lung Cancer Market (COVID-19) to Witness Astonishing Growth by Forecast 2019-2026

Description:

Global Non-Small Cell Lung Cancer Market is expected to rise gradually to an estimated value of USD 45.60 billion by 2026, registering a CAGR of 12.4% in the forecast period of 2019-2026 with the annual sales of USD 17.9 billion in year 2018. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients. – PowerPoint PPT presentation

Number of Views:44

less

Transcript and Presenter's Notes

Title: Non-Small Cell Lung Cancer Market (COVID-19) to Witness Astonishing Growth by Forecast 2019-2026


1
Non-Small Cell Lung Cancer Market (COVID-19) to
Witness Astonishing Growth by Forecast 2019-2026
Non-Small Cell Lung Cancer Market By Cancer Type
(Non-Small Cell Lung Cancer, Metastatic Lung
Cancer, Pulmonary Neuroendocrine Tumors,
Mediastinal Tumors, Mesothelioma, Chest Wall
Tumors), Molecule Type (Small Molecules,
Biologics), Drug Class (Alkylating Agents,
Antimetabolites, EGFR Inhibitors, Mitotic
Inhibitors, Multi-kinase Inhibitors, Others),
Treatment Type (Chemotherapy, Radiation Therapy,
Targeted Therapy, Immunotherapy, Others), Therapy
Type (Single Drug Therapy, Combination Therapy),
End User (Hospitals, Homecare, Specialty Clinics,
Others), Distribution Channel (Hospital Pharmacy,
Retail Pharmacy, Online, Others) Geography (North
America, South America, Europe, Asia-Pacific,
Middle East and Africa) Industry Trends
Forecast to 2026
Browse Full Report https//www.databridgemarke
tresearch.com/reports/global-non-small-cell-lung-c
ancer-market
2
Report Description
Global Non-Small Cell Lung Cancer Market is
expected to rise gradually to an estimated value
of USD 45.60 billion by 2026, registering a CAGR
of 12.4 in the forecast period of 2019-2026 with
the annual sales of USD 17.9 billion in year
2018. This rise in market value can be attributed
to the increasing awareness and concerns
regarding the health of patients. The lung
cancer is type of cancer which decreases the
efficiency of lungs to supply oxygen to the
bloodstream. This is one of the most common forms
of cancers which accounts for the highest
mortality rates. The lung cancer can be
categorized as an uncontrolled growth of cell in
the lungs. The main cause of lung cancers is
pipes, cigarette smoking, cigar smoking, and
asbestos exposure. Almost around 80.0 of the
total lung cancers are non-small cell lung
cancer.
Browse Full TOC https//www.databridgemarketre
search.com/toc/?dbmrglobal-non-small-cell-lung-ca
ncer-market
3
Major Key Players
  • Some of the major players operating in this
    market are
  • Takeda Pharmaceutical Company Limited (Japan)
  • Ono Pharmaceutical Co., Ltd. (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Novartis AG (Switzerland)
  • Eli Lilly And Company. (US)
  • Astrazeneca (UK)
  • Boehringer Ingelheim International Gmbh (Germany)
  • Merck Co., Inc. (Us)
  • Celgene Corporation (Us)
  • Amgen Inc. (Us)

Inquire Before Buying https//www.databridgemark
etresearch.com/inquire-before-buying/?dbmrglobal-
non-small-cell-lung-cancer-market
4
Market Segmentation
  • By Cancer Type (Non-Small Cell Lung Cancer,
    Metastatic Lung Cancer, Pulmonary Neuroendocrine
    Tumors, Mediastinal Tumors, Mesothelioma, Chest
    Wall Tumors)
  • By Molecule Type (Small Molecules, Biologics)
  • By Treatment Type (Chemotherapy, Radiation
    Therapy, Targeted Therapy, Immunotherapy, Others)

Get Exclusive Sample Report _at_ https//www.databri
dgemarketresearch.com/request-a-sample/?dbmrgloba
l-non-small-cell-lung-cancer-market
5
Regional Analysis
  • Based on geography, the market is segmented into
    five geographical regions
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East
  • Africa

6
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam Sopan.gedam_at_databridge
marketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com